According to FutureWise analysis the market for cell viability assays in 2023 is US$ 1.53 billion, and is expected to reach US$ 3.32 billion by 2031 at a CAGR of 10.2%.
Cell viability assays are technologies that are used for determining the cell strength in response to any tested drug. They are generally tested on a tissue, cell or an organ. Cell viability looks for the cells to identify any inorganic reaction which they aren’t supposed to follow and scale this reaction to mark its viability. This plays an important role in all forms of cell culture. Cell viability forms the basis of an assay to look out for drug effectiveness or cell viability with multiple combined particles and it also offers different characteristics of cell health to the user.
Cell viability assay is primarily performed in all in vitro and pharmaceutical studies due to increased applications of cell viability assays for drug screening. A large number of local manufacturers have expanded their cell viability assay kits product portfolio to determine effects in cell growth and cell death for the sake of clinical research and this has increased the demand for cell viability assays thus aiding the cell viability assays market size proliferation.